07-22-2022, 05:36 AM
Data from the drug registry regarding regularly prescribed asthma medications were used to calculate adherence. First, calculations were conducted for all common asthma treatments. Then, separate computations were conducted for routine prescriptions for corticosteroid-containing Asthalin inhaler USA and for corticosteroid-containing combination inhalers with long-acting beta2 agonists. The observation period began on each participant's first prescription filling date after January 1, 2008, and it terminated on each participant's last prescription filling date prior to June 30, 2012. "The expected average maintenance dose per day for a medicine used for its main indication in adults" is what is known as the defined daily dose .